The nucleic acid therapeutics CDMO market is expected to experience growth, with various reports forecasting its size and share by 2034. The market's expansion is likely driven by advancements in related fields, such as RNA therapeutics and lipid nanoparticles. However, the exact size and growth rate of the market are unclear, with different reports providing varying estimates and forecasts.